<DOC>
	<DOCNO>NCT00759811</DOCNO>
	<brief_summary>The aim study evaluate efficacy methotrexate improve physical capacity patient symptomatic ischemic heart failure .</brief_summary>
	<brief_title>METhotrexate Therapy Effects Physical Capacity Patients With ISchemic Heart Failure ( METIS Trial )</brief_title>
	<detailed_description>Recent study show importance proinflammatory mediator heart failure . However , lack benefit therapy try neutralize mediator . Methotrexate adenosine-mediated anti-inflammatory effect rheumatoid arthritis psoriasis . Methotrexate limit infarct size via adenosine-dependent mechanism heart dog ( J Cardiovasc Pharmacol . 2004 Apr ; 43 ( 4 ) :574-9 ) . A recent trial show drug reduce proinflammatory mediator patient heart failure ( Am Heart J . 2006 Jan ; 151 ( 1 ) :62-8 ) . These data suggest methotrexate may improve physical capacity patient ischemic heart failure reduce inflammation , randomize clinical trial necessary prove .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>Heart failure functional class measure use New York Heart Association classification class II , III IV Left ventricular fraction &lt; 0.45 ventriculography Angiographic coronary lesion higher 50 % coronary lesion revascularized ( coronary artery bypass percutaneous transluminal coronary angioplasty ) Myocardial infarction past four month Coronary artery bypass percutaneous transluminal coronary angioplasty past four month Left ventricular disfunction diagnose acute coronary syndrome Those require revascularization follow 12 week Hepatic disease ( ALT AST high upper limit reference value ) Renal failure ( plasma creatinine high 2.0mg/dl ) Alcoholism ( 20 dos per week ) Illegal drug use Rheumatoid arthritis inflammatory diseases Infectious disease Neoplasm Anemia ( hematocrit low 30 % ) Currently antiinflammatory drug Difficulty walk Unable understand/complete 36item Short Form health survey ( SF36 ) Those give informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Myocardial Ischemia</keyword>
	<keyword>Methotrexate</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Anti-Inflammatory Agents</keyword>
	<keyword>Inflammation Mediators</keyword>
</DOC>